MRC1 and breast carcinoma: Compared to other cancers with established biomarkers, such as PR, ER and HER-2 in breast cancer 12 and RAS, BRAF, MMR in colon cancer 13, PDAC lacks effective markers to assist in diagnosis, treatment and prognosis.